Tharimmune Inc.(THAR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

THAR Tharimmune Inc.

交易中 02-06 11:11:51 EST

4.17

+0.24

+6.11%

最高4.19	最低4.00	成交量49.14万
今开4.16	昨收3.93	日振幅4.96%
总市值1.65亿	流通市值1.46亿	总股本3,953万
成交额200.66万	换手率1.40%	流通股本3,511万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"THAR","market":"US","secType":"STK","nameCN":"Tharimmune Inc.","latestPrice":4.17,"timestamp":1770394194819,"preClose":3.93,"halted":0,"volume":491438,"delay":0,"changeRate":0.06106870229007628,"floatShares":35108800,"shares":39529800,"eps":-3.9051,"marketStatus":"交易中","change":0.24,"latestTime":"02-06 11:11:51 EST","open":4.155,"high":4.19,"low":3.995,"amount":2006634.72722,"amplitude":0.049618,"askPrice":4.2,"askSize":133,"bidPrice":4.16,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-3.9051,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":2,"adr":0,"listingDate":1641963600000,"exchange":"NASDAQ","adjPreClose":3.93,"preHourTrading":{"tag":"盘前","latestPrice":4.17,"preClose":3.93,"latestTime":"09:24 EST","volume":10360,"amount":43191.430519999994,"timestamp":1770387883678,"change":0.24,"changeRate":0.061069,"amplitude":0.045802},"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.93,"latestTime":"19:54 EST","volume":7984,"amount":31766.6039,"timestamp":1770339294795,"change":-0.01,"changeRate":-0.002545,"amplitude":0.030509},"volumeRatio":0.765206},"requestUrl":"/m/hq/s/THAR/tweets","defaultTab":"tweets","newsList":[{"id":"1132245775","title":"Tharimmune, Inc. 任命马克·温德兰为董事会主席，安吉拉·拉德科夫斯基为首席运营官","url":"https://stock-news.laohu8.com/highlight/detail?id=1132245775","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132245775?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:15","pubTimestamp":1770383724,"startTime":"0","endTime":"0","summary":"生物制药公司Tharimmune, Inc.宣布两项重要人事任命。公司正式任命马克·温德兰为董事会主席，同时擢升安吉拉·拉德科夫斯基为首席运营官。此次高层调整旨在强化公司治理结构，优化运营效率，为下一阶段的战略发展提供强有力的领导支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2593430618","title":"Tharimmune, Inc.盘中异动 早盘股价大涨9.48%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593430618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593430618?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:31","pubTimestamp":1766413907,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分，Tharimmune, Inc.股票出现波动，股价快速拉升9.48%。截至发稿，该股报2.54美元/股，成交量21.4924万股，换手率0.61%，振幅2.15%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"1194929374","title":"Tharimmune于11月7日任命Sireesh Appajosyula为临时首席财务官 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1194929374","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194929374?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:20","pubTimestamp":1763572807,"startTime":"0","endTime":"0","summary":"11月11日 - Tharimmune Inc ::*THARIMMUNE INC - 于11月7日任命Sireesh Appajosyula为临时首席财务官 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2582373562","title":"Tharimmune, Inc.盘中异动 临近午盘股价大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582373562?lang=zh_cn&edition=full","pubTime":"2025-11-12 00:30","pubTimestamp":1762878642,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时30分，Tharimmune, Inc.股票出现异动，股价快速下挫6.46%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"gpt_icon":0},{"id":"2580146852","title":"上市公司 Tharimmune 完成约 5.4 亿美元私募融资，将建立 Canton Coin 财库","url":"https://stock-news.laohu8.com/highlight/detail?id=2580146852","media":"链捕手","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580146852?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:13","pubTimestamp":1762179232,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 PR Newswire 报道，纳斯达克上市公司 Tharimmune, Inc.（NASDAQ: THAR）宣布完成约 5.4 亿美元私募融资，每股价格 3.075 美元。\n\n本轮融资由 DRW 和 Liberty City Ventures 领投，参投方包括 ARK Invest、Bitwave、Broadridge、Clear Street、Copper、Digital Asset、Polychain Capital、SBI Group、Kraken 等知名机构，Canton 基金会也参与了此次融资。\n\n该公司计划将净收益用于收购 Canton Coin（CC）代币，这是支持 Canton 网络互操作性和结算的实用代币。Tharimmune 将作为超级验证者运营，并在 Canton 网络上运行额外验证者以获得更多 CC 代币。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2217032","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4098","TSYW.SI",".IXIC","NVIW.SI","THAR","MNQmain","USJW.SI","QID","USAW.SI","PSQ","BK4139","QLD","TQQQ","CC","SQQQ"],"gpt_icon":0},{"id":"1107182154","title":"Tharimmune Inc.宣布约5.4亿美元的私募融资，由Drw和Liberty City Ventures主导，以制定Canton Coin国库战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1107182154","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107182154?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:05","pubTimestamp":1762178709,"startTime":"0","endTime":"0","summary":"Tharimmune Inc.宣布约5.4亿美元的私募融资，由Drw和Liberty City Ventures主导，以制定Canton Coin国库战略","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2577387943","title":"Tharimmune, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577387943?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:59","pubTimestamp":1761055143,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时59分，Tharimmune, Inc.股票出现异动，股价快速下挫5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1205.30%、166.31%、49.04%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、78.99%、47.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"gpt_icon":0},{"id":"2575477592","title":"Tharimmune, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575477592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575477592?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:04","pubTimestamp":1760461453,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时04分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.04%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2802.30%、38.15%、37.55%，振幅较大的相关个股有Pmgc Holdings Inc.、Cdt Equity Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为55.85%、38.33%、37.50%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"gpt_icon":0},{"id":"2574432962","title":"Tharimmune, Inc.盘中异动 早盘急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574432962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574432962?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:39","pubTimestamp":1760107161,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时39分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Gyre Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Q32 Bio Inc.涨幅较大，Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃，换手率分别为321.98%、70.15%、49.71%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026、知临集团，振幅分别为39.68%、33.20%、29.54%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2558624206","title":"Tharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558624206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558624206?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:10","pubTimestamp":1754935817,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时10分，Tharimmune, Inc.股票出现异动，股价快速上涨5.32%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6092.92%、628.08%、438.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0},{"id":"2516670075","title":"Tharimmune, Inc.盘中异动 大幅下挫6.21%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670075?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Tharimmune, Inc.股票出现异动，股价快速下挫6.21%。截至发稿，该股报1.36美元/股，成交量56.5869万股，换手率29.26%，振幅0.69%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PBC","THAR"],"gpt_icon":0},{"id":"2514686977","title":"Tharimmune, Inc.盘中异动 下午盘快速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514686977?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:02","pubTimestamp":1740596538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时02分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.67%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6518.56%、288.25%、256.53%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、81.11%、52.76%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2506889898","title":"Tharimmune, Inc.盘中异动 股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506889898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506889898?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:24","pubTimestamp":1737735891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时24分，Tharimmune, Inc.股票出现异动，股价快速下挫6.02%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Evaxion Biotech As、Neuphoria Therapeutics Inc.、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3872.49%、2103.81%、1560.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Neuphoria Therapeutics Inc.，振幅分别为134.08%、112.09%、107.98%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2494384917","title":"Tharimmune, Inc.盘中异动 早盘大幅下挫6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494384917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494384917?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:32","pubTimestamp":1735313558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时32分，Tharimmune, Inc.股票出现异动，股价大幅下跌6.98%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Galectin Therapeutics Inc.、Abpro Holdings, Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为103.36%、45.37%、20.70%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为65.39%、62.45%、58.33%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233238ab94ffbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233238ab94ffbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"gpt_icon":0},{"id":"2490043841","title":"Tharimmune, Inc.盘中异动 股价大跌8.23%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490043841?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841071,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Tharimmune, Inc.股票出现波动，股价快速跳水8.23%。截至发稿，该股报2.12美元/股，成交量4.6069万股，换手率3.10%，振幅0.00%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223111a1e397b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223111a1e397b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"2489122413","title":"Tharimmune, Inc.盘中异动 临近收盘快速下跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489122413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489122413?lang=zh_cn&edition=full","pubTime":"2024-12-06 05:01","pubTimestamp":1733432478,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日05时01分，Tharimmune, Inc.股票出现异动，股价快速下挫5.58%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Protara Therapeutics, Inc.、Camp4 Therapeutics Corporation、Molecular Templates, Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3780.95%、2384.54%、535.36%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为136.00%、127.97%、124.83%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120605011898e5ad75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120605011898e5ad75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2486014060","title":"Tharimmune, Inc.盘中异动 股价大跌7.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486014060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486014060?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631647,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，Tharimmune, Inc.股票出现异动，股价急速下挫7.75%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.86%、10.36%、8.59%，振幅较大的相关个股有Caribou Biosciences, Inc.、Cabaletta Bio, Inc.、Exicure, Inc.，振幅分别为13.61%、13.54%、12.72%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223407971a8a0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223407971a8a0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0},{"id":"2485261222","title":"Tharimmune, Inc.盘中异动 股价大跌5.75%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261222?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:47","pubTimestamp":1732286826,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时47分，Tharimmune, Inc.股票出现波动，股价大幅下挫5.75%。截至发稿，该股报2.46美元/股，成交量7981股，换手率0.54%，振幅3.83%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224706abd7992f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224706abd7992f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4007","BK4139","THAR","VRPX"],"gpt_icon":0},{"id":"2485049705","title":"Tharimmune, Inc.盘中异动 早盘大幅下挫5.60%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485049705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485049705?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199486,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分，Tharimmune, Inc.股票出现异动，股价急速跳水5.60%。截至发稿，该股报2.36美元/股，成交量3944股，换手率0.27%，振幅2.40%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223126abd4e62c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223126abd4e62c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","THAR","BK4139"],"gpt_icon":0},{"id":"2484667987","title":"Tharimmune, Inc.盘中异动 早盘快速上涨5.07%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484667987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484667987?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940333,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Tharimmune, Inc.股票出现异动，股价快速拉升5.07%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.39%、196.71%、186.34%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为46.50%、31.28%、19.34%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822321395be485f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822321395be485f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tharimmune.com","stockEarnings":[{"period":"1week","weight":-0.1208},{"period":"1month","weight":0.2718},{"period":"3month","weight":-0.0621},{"period":"6month","weight":2.1848},{"period":"1year","weight":0.965},{"period":"ytd","weight":0.297}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tharimmune, Inc.于2017年3月28日作为特拉华州公司注册成立。该公司是一家临床前生物技术公司，开发针对铁死亡的新型治疗候选药物，铁死亡是一种新兴的抗癌机制，导致IMCD用于治疗耐药性癌症。他们拥有的最先进的候选产品是HSB-1216，一种IMCD诱导剂，针对各种实体瘤。该公司使用其专有的肿瘤靶向平台Quatrame来增强HSB-1216在TME中的吸收，延长作用持续时间和最小的脱靶毒性。此外，他们的人工智能精准医疗平台Trident用于识别临床项目中的生物标志物，以针对特定的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.63058},{"month":2,"riseRate":0,"avgChangeRate":-0.244232},{"month":3,"riseRate":0.25,"avgChangeRate":-0.086128},{"month":4,"riseRate":0.25,"avgChangeRate":-0.137764},{"month":5,"riseRate":0,"avgChangeRate":-0.1932},{"month":6,"riseRate":0.5,"avgChangeRate":-0.002598},{"month":7,"riseRate":0.25,"avgChangeRate":0.005824},{"month":8,"riseRate":0.25,"avgChangeRate":0.782187},{"month":9,"riseRate":0,"avgChangeRate":-0.237509},{"month":10,"riseRate":0.5,"avgChangeRate":-0.086608},{"month":11,"riseRate":0,"avgChangeRate":-0.367326},{"month":12,"riseRate":0.25,"avgChangeRate":-0.064769}],"exchange":"NASDAQ","name":"Tharimmune Inc.","nameEN":"Tharimmune Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tharimmune Inc.(THAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tharimmune Inc.(THAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tharimmune Inc.,THAR,Tharimmune Inc.股票,Tharimmune Inc.股票老虎,Tharimmune Inc.股票老虎国际,Tharimmune Inc.行情,Tharimmune Inc.股票行情,Tharimmune Inc.股价,Tharimmune Inc.股市,Tharimmune Inc.股票价格,Tharimmune Inc.股票交易,Tharimmune Inc.股票购买,Tharimmune Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tharimmune Inc.(THAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tharimmune Inc.(THAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}